Dr Saklad was born in Los Angeles, California. He graduated from Pacific Palisades High School and received his baccalaureate degree in bacteriology from UCLA. His Doctor of Pharmacy degree was earned at USC in 1978. He did a NIMH fellowship in psychiatric pharmacy at the University of Nebraska Medical Center at Omaha in 1978-9, with Jim Wilson, Pharm.D., BCPP, and joined the faculty of The University of Texas College of Pharmacy in 1979. He has lived in San Antonio, Texas since 1979. He is married and the father of triplet sons.

He was the first clinical pharmacist hired by the Texas Department of Mental Health and Mental Retardation (now the Texas Department of State Health Services) when be began as clinical coordinator at San Antonio State Hospital in 1979.

Dr Saklad has provided care in a variety of settings and treatment roles at San Antonio State Hospital. Wrote and successfully lobbied for the creation of a clinical research unit at San Antonio State Hospital funded by the Texas Legislature and governed by the College of Pharmacy, Department of Psychiatry and San Antonio State Hospital. He developed the first websites for The University of Texas College of Pharmacy in 1994 and the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997. He is the director of the University of Texas Psychiatric Pharmacy Residency Program in San Antonio. In 2003, he was elected to the Board of Directors of the College of Psychiatric and Neurologic Pharmacists for a two-year term.

He has published articles and presented to many groups around the country on a variety of pharmacy and mental health related topics. He was the editor of "Psychopharmacology Update," a newsletter, from 1998-2002. He has edited two editions of a compendium based upon this newsletter: Psychopharmacology Desktop Reference, published by Manisses Communications Group in 1999 and 2002. He was the first editor of the Journal of the College of Psychiatric and Neurologic Pharmacists (JCPNP), which began publication as a peer-reviewed online journal in 2002. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illness, as well as their pharmacokinetics and interactions.

More information about Dr. Saklad
> Honors & Awards